Lead Product(s): Dexamethasone
Therapeutic Area: Ophthalmology
Highest Development Status: Phase II Product Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 22, 2020
The Phase 2 trial data is the first controlled study of OCS-01 for the treatment of DME.